[Federal Register Volume 85, Number 173 (Friday, September 4, 2020)]
[Notices]
[Page 55291]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19642]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Interagency Committee on Smoking and Health (ICSH)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting of the Interagency Committee on Smoking and Health 
(ICSH). This is a virtual meeting and is open to the public. The public 
is welcome to view the meeting via Zoom, limited only by the number of 
seats available, which is 500. This meeting will include time for 
members of the public to make an oral comment. Priority will be given 
to individuals who submit a request to make an oral public comment 
before the meeting according to the procedures below.

DATES: The meeting will be held on October 15, 2020 from 12:30 p.m. to 
4:00 p.m., EDT.

ADDRESSES: Zoom Virtual Meeting. For more information, including 
information regarding registration and login, please visit: https://www.cdc.gov/tobacco/about/icsh/index.htm.

FOR FURTHER INFORMATION CONTACT: Kathryn Gallagher, Alternate 
Designated Federal Officer, MPH, Interagency Committee on Smoking and 
Health, CDC, 4770 Buford Highway NE, Atlanta, Georgia 30341, telephone 
(404) 639-6358; [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Interagency Committee on Smoking and Health shall 
provide advice and guidance to the Secretary, Department of Health and 
Human Services (HHS), regarding: (a) Coordination of research, 
educational programs, and other activities within the Department that 
relate to the effect of smoking on human health and on coordination of 
these activities, with similar activities of other Federal and private 
agencies; and (b) establishment and maintenance of liaisons with 
appropriate private entities, other Federal agencies, and State and 
local public agencies, regarding activities relating to the effect of 
cigarette smoking on human health.
    Matters to be considered: The agenda will include discussions on 
the topic of youth tobacco cessation. The meeting objective is to 
identify federal actions to prioritize areas of research that can be 
expedited to support tobacco cessation treatments for youth. Agenda 
items are subject to change as priorities dictate.
    Procedure for oral public comment: All persons interested in making 
an oral public comment at the October ICSH meeting must submit an email 
request, according to the instructions provided, to Jade Chambers-Blair 
at [email protected], no later than 11:59 p.m., EDT, October 8, 2020. The 
email request should include the speaker's first and last name, 
organization, address, phone, and email. CDC will allow for as many 
comments as permitted by time and will queue individuals for comment in 
the order in which their requests were received. CDC staff will notify 
individuals regarding their request to speak by email by October 11, 
2020. To accommodate the interest in participation in the oral public 
comment session of ICSH meetings, each speaker will be limited to 2 
minutes, and each speaker may only speak once per meeting.
    For more information on ICSH please visit the CDC.gov webpage: 
https://www.cdc.gov/tobacco/about/icsh/index.htm.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-19642 Filed 9-3-20; 8:45 am]
BILLING CODE 4163-18-P